PTC Therapeutics PTCT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $984.65M+26.3% | $779.71M+31.3% | $594M+112% | $279.83M+47.5% | ||
| $960.72M+167% | $359.99M+27.3% | $282.74M+116% | $130.87M-77.6% | ||
| $181.62M+14.5% | $158.55M-1.4% | $160.82M+3.3% | $155.61M+40.9% | ||
| $79.65M+243% | $23.19M-24.1% | $30.58M+40.2% | $21.81M+37.5% | ||
| $67.31M+52.7% | $44.09M-70.7% | $150.49M+42.4% | $105.66M+93.2% | ||
| $2.27B+66.5% | $1.37B+12.1% | $1.22B+75.6% | $693.79M-27.3% | ||
| $55.37M-9.2% | $60.97M-30.0% | $87.09M+20.0% | $72.59M+38.0% | ||
| $80.05M+41.2% | $56.69M-38.3% | $91.9M-10.3% | $102.43M+32.3% | ||
| $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | ||
| $388.75M+227% | $118.79M-68.7% | $379.5M-46.2% | $705.89M-2.6% | ||
| —— | -$55.91M-200% | $55.91M-45.6% | $102.83M-25.0% | ||
| $2.9B+70.0% | $1.71B-10.1% | $1.9B+11.1% | $1.71B-12.0% | ||
| $381.27M+25.3% | $304.29M-22.4% | $391.98M+22.4% | $320.37M+10.9% | ||
| $2.04M-62.9% | $5.51M+587% | $801K-40.7% | $1.35M— | ||
| $286.63M+9,454% | $3M0.0% | $3M0.0% | $3M-98.0% | ||
| $12.48M+20.5% | $10.36M-20.3% | $13M+38.8% | $9.37M+28.8% | ||
| $3M0.0% | $3M0.0% | $3M0.0% | $3M0.0% | ||
| $968.43M+66.7% | $580.98M-3.7% | $603.1M+48.5% | $406.24M-20.2% | ||
| $93.58M+24.9% | $74.95M-23.2% | $97.63M-3.2% | $100.86M+37.0% | ||
| $3M-80.7% | $15.57M-9.4% | $17.18M-8.0% | $18.68M-6.9% | ||
| $13.7M-36.0% | $21.43M+15,096% | $141K-94.7% | $2.64M— | ||
| $3.1B+10.7% | $2.8B+3.3% | $2.71B+32.2% | $2.05B+6.0% | ||
| $80K+3.9% | $77K+2.7% | $75K+4.2% | $72K+1.4% | ||
| $2.75B+6.7% | $2.57B+4.4% | $2.47B+7.0% | $2.31B+8.5% | ||
| -$2.96B+18.7% | -$3.65B-11.1% | -$3.28B-23.6% | -$2.66B-26.6% | ||
| $10.5M+141% | -$25.89M-1,914% | -$1.29M-127% | $4.8M+120% | ||
| -$205.31M+81.3% | -$1.1B-34.1% | -$818.56M-136% | -$347.09M-24,237% | ||
| $2.9B+70.0% | $1.71B-10.1% | $1.9B+11.1% | $1.71B-12.0% | ||
| $960.72M+167% | $359.99M+27.3% | $282.74M+116% | $130.87M-77.6% | ||
| $80.05M+41.2% | $56.69M-38.3% | $91.9M-10.3% | $102.43M+32.3% | ||
| $18.3M-11.6% | $20.7M-42.9% | $36.25M-25.4% | $48.58M+4.5% | ||
| $388.75M+227% | $118.79M-68.7% | $379.5M-46.2% | $705.89M-2.6% | ||
| $80.05M+41.2% | $56.69M-38.3% | $91.9M-10.3% | $102.43M+32.3% | ||
| $80.05M+41.2% | $56.69M-38.3% | $91.9M-10.3% | $102.43M+32.3% | ||
| $381.27M+25.3% | $304.29M-22.4% | $391.98M+22.4% | $320.37M+10.9% | ||
| $283M+9.8% | $257.82M+32.7% | $194.31M+169% | $72.15M+21.7% | ||
| $398.7M+1.6% | $392.3M-6.2% | $418.03M-40.8% | $706.63M+32.0% | ||
| $80K+3.9% | $77K+2.7% | $75K+4.2% | $72K+1.4% | ||
| $3M0.0% | $3M0.0% | $3M0.0% | $3M0.0% | ||
| $2.03B+11.0% | $1.82B+12.6% | $1.62B+136% | $685.74M+1.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are PTC Therapeutics's total assets?
- PTC Therapeutics (PTCT) holds $2.9B in total assets, up 8.1% year over year.
- How much debt does PTC Therapeutics have?
- PTC Therapeutics carries $395.1M in total debt against -$180.5M of shareholders' equity, a debt-to-equity ratio of 372.31.
- How much cash does PTC Therapeutics have?
- PTC Therapeutics holds $834.0M in cash and equivalents.
- Can PTC Therapeutics cover its short-term obligations?
- Its current ratio is 2.44 — current assets exceed current liabilities.
- Where does PTC Therapeutics's balance sheet data come from?
- Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
